Herman Mielants

20.3k citations
214 papers · 10.9k indexed · 1 hit paper · h-index 49
Topics
Spondyloarthritis Studies and Treatments (122 papers)Rheumatoid Arthritis Research and Therapies (83 papers)Psoriasis: Treatment and Pathogenesis (50 papers)
Partner nations
BelgiumNetherlandsFrance

In The Last Decade

Herman Mielants

208 papers receiving 10.4k citations

Hit Papers

Classification criteria for psoriatic arthritis: Developm...2006202620122019200650010001.5k2.0k2.5k

Peers

Herman Mielants
Comparison fields: 5 of 126
  • Rheumatology 8.6k
  • Immunology 4.9k
  • Hematology 3.3k
  • Genetics 1.6k
  • Epidemiology 1.1k
Replace H. Zeidler with:
H. Zeidler Germany
Filip Van den Bosch Belgium
Andrei Călin United Kingdom
A. Cats Netherlands
Joachim Listing Germany
Daniel Wendling France
B Amor France
Peter Nash Australia
Martín Rudwaleit Germany
Atul Deodhar United States
Herman Mielants relative to H. Zeidler Germany H. Zeidler's profile →
Citations per field
00.5×2.7×
H. Zeidler · 1×
Citations per year

Countries citing papers authored by Herman Mielants

Since Specialization
Citations

This map shows the geographic impact of Herman Mielants's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Mielants with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Mielants more than expected).

Fields of papers citing papers by Herman Mielants

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herman Mielants. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Mielants. The network helps show where Herman Mielants may publish in the future.

Co-authorship network of co-authors of Herman Mielants

This figure shows the co-authorship network connecting the top 25 collaborators of Herman Mielants. A scholar is included among the top collaborators of Herman Mielants based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herman Mielants. Herman Mielants is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
A nationwide survey on patient's versus physician's evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the Be-Raise study
1
2
Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis
2
3
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.
1
4
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect
1
5
Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype
2
6
Bowel inflammation in rheumatic diseases: Trigger or consequence
1
7
Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years
1
8
Short and long term synovial immunumodulation by etanercept in spondyloarthropathy
1
9
The SF-6D differentiates less in the lower ranges of the patient's utility when compared with the EQ-5D but has a better reliability and sensitivity to change
1
10 11
11 9
12
T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease
3
13 6
14
Gastrointestinal tract and rheumatic disease
1
15
Ileitis in the spondylarthropathies
1
16
Clinical aspects of enterogenic arthropathies
1
17
2nd Conference on spondylarthropathies and the gut, Gent, Belgium, 1-2 July 1993
2
18
Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation.
13
19 26
20 19

About Herman Mielants

Herman Mielants is a scholar working on Rheumatology, Immunology and Complementary and Manual Therapy, having authored 214 papers that have together received 10.9k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (122 papers), Rheumatoid Arthritis Research and Therapies (83 papers) and Psoriasis: Treatment and Pathogenesis (50 papers). The work is most often cited by research in Rheumatology (8.6k citations), Hematology (3.3k citations) and Immunology (4.9k citations). Herman Mielants has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Eric Veys, Antonio Marchesoni, William J. Taylor, Philip J. Mease, Philip Helliwell, Dafna D. Gladman, Filip De Keyser, Claude Cuvelier, Martine De Vos and Désirée van der Heijde. Their work appears in journals such as The Lancet, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026